Army biodefense lab mishaps potentially exposed Md. workers
Two accidents at the Army's flagship biodefense laboratory potentially exposed nine workers to harmful biological agents in the last two years, according to occupational hazard reports.
Editorial: A chemical giant reborn
The announcement right before the holidays that Worthington Industries is closing its steel-processing plant in Essex is a reminder of the long, grinding attrition of Maryland’s traditional strengths in manufacturing and heavy industry.
Maryland to ban arsenic in chicken feed
ANNAPOLIS — Gov. Martin O’Malley is expected to sign a bill this week that would make Maryland the first state to ban an arsenic additive in chicken feed. Last month, state lawmakers passed a bill banning the use of Roxarsone, a chemical used to help the birds grow and fight parasites. Pfizer Inc., which distributes […]
Court affirms dismissal of Alcolac poison-gas lawsuit
RICHMOND — A federal appeals court has upheld the dismissal of a lawsuit alleging the chemical company Alcolac Inc. illegally sold chemical-weapons materials to the Saddam Hussein regime in the 1980s. A three-judge panel of the 4th U.S. Circuit Court of Appeals unanimously agreed Monday with a federal judge in Maryland who ruled that Alcolac, […]
Columbia-based W.R. Grace chosen for energy research
The U.S. Department of Energy has selected Columbia-based specialty chemical company W.R. Grace & Co. to conduct one of 16 research projects nationwide aimed at improving the efficiency and reducing the cost of advanced carbon-capture systems at coal-fired power plants. DOE is giving Grace $3 million to fund about 80 percent of the cost of […]
Annapolis-based PharmAthene gets $5.7M DoD contract
ANNAPOLIS — PharmAthene Inc. of Annapolis, a company developing medical defenses against biological and chemical threats, said it has been awarded a $5.7 million, 18-month contract by the U.S. Department of Defense to continue development of a counter-measure to ward off the physical effects of chemical nerve agents. According to the company, preclinical studies in […]